← Leaderboards
Jingsong Zhou
Rush University Medical Center
$5,614,980
Attributed
$11,509,354
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,509,354 · 5
By mechanism
R01$11,509,354 · 5
Top collaborators
- Jianjie Ma9 shared
- Marco Brotto5 shared
- Ki Ho Park4 shared
- Hua Zhu4 shared
- Lyle Wilfred Ostrow3 shared
- Pei-Hui Lin2 shared
Others in their field
Top investigators on “Functional Disorder”
- Randall J Bateman · Washington University$164,791,794
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- David Heimbrook · Leidos Biomedical Research, Inc.$127,725,513
- Ed Lein · Allen Institute$92,850,604
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- John M Lachin · George Washington University$85,958,868
Research focus
Functional DisorderPathologyGenesMitochondriaMuscleDefectMolecularSignal TransductionOxidative StressMitochondrial DysfunctionPhysiologyMouse ModelAffectMediatingSkeletal MuscleStressPhysiologicalLinkMutationResponsePlayIn VivoDisease ProgressionNeuromuscular Junction
Grant awards (22)
Multifaceted role of MG53 in alleviating neuromuscular function decline in ALS$626,652
R01 · FY2025 · NS · contact PI
MG53 function in muscle aging$604,073
R01 · FY2025 · AG
Multifaceted role of MG53 in alleviating neuromuscular function decline in ALS$617,807
R01 · FY2024 · NS · contact PI
MG53 function in muscle aging$617,042
R01 · FY2024 · AG
Multifaceted role of MG53 in alleviating neuromuscular function decline in ALS$674,418
R01 · FY2023 · NS · contact PI
MG53 function in muscle aging$617,673
R01 · FY2023 · AG
Preserving Mitochondrial Function for Alleviating ALS Progression$554,482
R01 · FY2023 · NS · contact PI
MG53 function in muscle aging$649,040
R01 · FY2022 · AG
Preserving mitochondrial function for alleviating ALS progression$570,776
R01 · FY2022 · NS · contact PI
Ca signaling cross-talk from SR to mitochondria in heart muscle$647,488
R01 · FY2021 · HL
Preserving mitochondrial function for alleviating ALS progression$591,508
R01 · FY2021 · NS · contact PI
Ca signaling cross-talk from SR to mitochondria in heart muscle$649,845
R01 · FY2020 · HL
Preserving mitochondrial function for alleviating ALS progression$578,155
R01 · FY2020 · NS · contact PI
Ca signaling cross-talk from SR to mitochondria in heart muscle$653,033
R01 · FY2019 · HL
Preserving mitochondrial function for alleviating ALS progression$583,090
R01 · FY2019 · NS · contact PI
Ca signaling cross-talk from SR to mitochondria in heart muscle$670,127
R01 · FY2018 · HL
Ca Signaling in Progression of Amyotrophic Lateral Sclerosis in Skeletal Muscle$165,546
R01 · FY2014 · AR · contact PI
Ca Signaling in Progression of Amyotrophic Lateral Sclerosis in Skeletal Muscle$157,107
R01 · FY2014 · AR · contact PI
Ca Signaling in Progression of Amyotrophic Lateral Sclerosis in Skeletal Muscle$307,800
R01 · FY2013 · AR · contact PI
Ca Signaling in Progression of Amyotrophic Lateral Sclerosis in Skeletal Muscle$324,000
R01 · FY2012 · AR · contact PI
Ca Signaling in Progression of Amyotrophic Lateral Sclerosis in Skeletal Muscle$321,192
R01 · FY2011 · AR · contact PI
Ca Signaling in Progression of Amyotrophic Lateral Sclerosis in Skeletal Muscle$328,500
R01 · FY2010 · AR · contact PI